Podcast: Facilitating Patient Monitoring in CAR-T Development

30 Apr 2024

In Partnership with Cerba Research

T-cells attacking cancer_1200x675 — • Source: Shutterstock

Listen in on the conversation as experts from Cerba Research discuss facilitating patient safety measures in CAR-T therapies by accurately identifying the integration of viral vectors, utilizing flow cytometry, and more.

Listen now as experts discuss answers to:

What patient monitoring is required by the FDA?
What molecular technology does Cerba Research use and how does it meet FDA requirements?
What is the importance of cytometry assays in monitoring CAR-T cells?
What are the opportunities for combining flow cytometry with genomic solutions?
What key innovations are poised to improve patient monitoring in clinical trials?

Citeline · Podcast: Facilitating Patient Monitoring in CAR-T Development

Open Media

In Partnership with Cerba Research

GSK’s Nucala Set For Dupixent Face-Off After FDA COPD Nod

23 May 2025

• By Kevin Grogan

The UK major's asthma drug gets a key expanded approval.

Merus Bispecific Impresses In Head And Neck Cancer

23 May 2025

• By Andrew McConaghie

Updated Phase II results from petosemtamab have impressed ahead of ASCO, outshining Keytruda monotherapy and its bispecific rival from Bicara.

Boehringer’s CMO On How AI, Integrated Evidence Generation Underpin Its Ambitious Launch Plans

22 May 2025

• By Alexandra Shimmings

The German company has big plans for the next five years or so. Scrip speaks to its chief medical officer Lykke Hinsch Gylvin about how it is using AI and other innovative approaches to make good on its ambitions.